Companies Dominating the Mucous Membrane Decontamination Landscape
- Astellas Pharma Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bausch Health Companies Inc.
- Genentech, Inc.
- Lipidor AB
- Pfizer Inc.
- Merck & Co., Inc.
- Sun Pharmaceutical Industries Limited
- EPI Health, LLC
- Mölnlycke Health Care AB
- Reckitt Benckiser Group plc
Browse Key Market Insights with Data Illustration:
In the News
-
Astellas Pharma Inc. announced its global strategic collaboration with Sutro Biopharma, Inc. along with licensing agreement to improvise the development procedure of novel immunostimulatory antibody-drug conjugates shortly known as iADCs.
-
Sun Pharmaceutical Industries Limited and its entirely owned subsidiaries launched an oral drug, Bempedoic Acid, under the brand name Brillo in India which focuses on low-density lipoprotein cholesterol to be decreased.
